Why the study?
It remained unclear whether endovascular aneurysm repair is less effective than open surgery in the long term due to the need for reinterventions and close monitoring.
Does endovascular aneurysm repair (EVAR) provide comparable long-term survival and reintervention rates to open surgical repair (OSR) in patients with abdominal aortic aneurysms, including those treated outside of instructions for use (IFU) criteria?
Does endovascular aneurysm repair (EVAR) provide comparable long-term survival and reintervention rates to open surgical repair (OSR) in patients with abdominal aortic aneurysms, including those treated outside of instructions for use (IFU) criteria?
EVAR offers similar long-term survival to open surgical repair for abdominal aortic aneurysms, even in patients treated outside of instructions for use (IFU) criteria, despite a higher need for late reinterventions.
Comparable long-term survival supports EVAR consideration even outside IFU; leaves open reintervention burden and optimal selection in real-world cohorts.
PURPOSE: It remains unclear whether endovascular aneurysm repair, in the long term, is less effective than open surgery due to need for reinterventions and close monitoring. We aimed to evaluate this matter in a real-life cohort. METHODS: We collected consecutive patients treated with EVAR or OSR between January 2005 and December 2013. Primary outcomes were 30-day, 90-day and long-term all-cause mortality. Secondary outcomes were 30-day reintervention rate and reintervention-free survival. We evaluated also a subpopulation who did not adhere to IFU. RESULTS: The inclusion criteria were met by 416 patients. 258 (62%) received EVAR, while 158 (38%) underwent OSR. The 30- or 90-day mortality was similar between groups (p = 0.272 and p = 0.346), as ARM (p = 0.652). The 30-day reintervention rate was higher in the OSR group (p < 0.001), but during follow-up, it was significantly higher in the EVAR group (log-rank: 0.026). There were 114 (44.2%) non-IFU patients in the EVAR group, and we compared them with OSR group. There was no significant difference in all-cause mortality at 30 or 90 days, nor in the long term (p = 1; p = 1 and p = 0.062). ARM was not affected by the procedure technique (p = 0.136). The short-term reintervention rate was higher in the OSR group (p = 0.003), while in the long-term EVAR, patients experienced more reinterventions (log-rank = 0.0.43). CONCLUSION: No significant difference in survival was found between EVAR and OSR, independent of adherence to IFU. EVAR may be considered for surgical candidates.
No takes yet. Share an insight, caveat, or question.
Protto et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: